Athens Medical C.S.A. (IATR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Athens Medical C.S.A. (IATR) has a cash flow conversion efficiency ratio of 0.029x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€3.17 Million ≈ $3.71 Million USD) by net assets (€108.78 Million ≈ $127.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Athens Medical C.S.A. - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Athens Medical C.S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Athens Medical C.S.A. total liabilities for a breakdown of total debt and financial obligations.
Athens Medical C.S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Athens Medical C.S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sajo Ind
KO:007160
|
-0.007x |
|
Havilah Resources Ltd
AU:HAV
|
-0.010x |
|
Jinzhou Port Co Ltd A
SHG:600190
|
-22.872x |
|
Venu Holding Corporation
NYSE MKT:VENU
|
0.065x |
|
Is Girisim Sermayesi Yatirim Ortakligi AS
IS:ISGSY
|
-0.007x |
|
Cyberlink Co
TW:5203
|
-0.032x |
|
Jean Co Ltd
TW:2442
|
0.122x |
|
Anterogen.Co.Ltd
KQ:065660
|
0.003x |
Annual Cash Flow Conversion Efficiency for Athens Medical C.S.A. (2014–2024)
The table below shows the annual cash flow conversion efficiency of Athens Medical C.S.A. from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see IATR company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €108.81 Million ≈ $127.21 Million |
€46.44 Million ≈ $54.30 Million |
0.427x | +77.67% |
| 2023-12-31 | €108.77 Million ≈ $127.16 Million |
€26.13 Million ≈ $30.55 Million |
0.240x | +19904.30% |
| 2022-12-31 | €103.25 Million ≈ $120.71 Million |
€124.00K ≈ $144.97K |
0.001x | -99.22% |
| 2021-12-31 | €102.06 Million ≈ $119.32 Million |
€15.75 Million ≈ $18.41 Million |
0.154x | -66.59% |
| 2020-12-31 | €87.07 Million ≈ $101.79 Million |
€40.21 Million ≈ $47.01 Million |
0.462x | +15.96% |
| 2019-12-31 | €79.08 Million ≈ $92.46 Million |
€31.50 Million ≈ $36.82 Million |
0.398x | +42.46% |
| 2018-12-31 | €71.62 Million ≈ $83.73 Million |
€20.02 Million ≈ $23.41 Million |
0.280x | +1258.18% |
| 2017-12-31 | €63.18 Million ≈ $73.87 Million |
€-1.52 Million ≈ $-1.78 Million |
-0.024x | -114.98% |
| 2016-12-31 | €60.65 Million ≈ $70.91 Million |
€9.78 Million ≈ $11.43 Million |
0.161x | -26.39% |
| 2015-12-31 | €58.85 Million ≈ $68.80 Million |
€12.89 Million ≈ $15.07 Million |
0.219x | +350.93% |
| 2014-12-31 | €73.81 Million ≈ $86.29 Million |
€3.58 Million ≈ $4.19 Million |
0.049x | -- |
About Athens Medical C.S.A.
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and … Read more